Rep. Lisa C. McClain Sells Off Shares of Globus Medical, Inc. (NYSE:GMED)

Key Points

• Representative Lisa C. McClain sold shares of Globus Medical, Inc. (NYSE:GMED) worth between $1,001 and $15,000 on July 10th, 2023.
• Globus Medical reported a quarterly earnings per share of $0.86, exceeding analyst expectations of $0.76, alongside an 18.4% increase in revenue year-over-year.
• The company has launched a $500 million share buyback plan, indicating management's belief that the stock is currently undervalued.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Globus Medical, Inc. NYSE: GMED. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Globus Medical stock on July 10th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Globus Medical Price Performance

Shares of NYSE:GMED traded up $0.19 on Thursday, reaching $60.92. 115,405 shares of the company traded hands, compared to its average volume of 1,446,358. Globus Medical, Inc. has a fifty-two week low of $51.79 and a fifty-two week high of $94.93. The company's 50 day moving average is $57.22 and its 200-day moving average is $66.84. The stock has a market capitalization of $8.23 billion, a PE ratio of 23.42, a P/E/G ratio of 1.71 and a beta of 1.20.

Globus Medical (NYSE:GMED - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical device company reported $0.86 EPS for the quarter, beating analysts' consensus estimates of $0.76 by $0.10. Globus Medical had a return on equity of 10.65% and a net margin of 13.58%.The company had revenue of $745.34 million during the quarter, compared to the consensus estimate of $738.91 million. During the same quarter in the prior year, the firm earned $0.75 EPS. The company's quarterly revenue was up 18.4% compared to the same quarter last year. As a group, analysts expect that Globus Medical, Inc. will post 3.44 EPS for the current year.

Globus Medical announced that its Board of Directors has approved a share repurchase plan on Thursday, May 15th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the medical device company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its shares are undervalued.

Hedge Funds Weigh In On Globus Medical

Hedge funds have recently bought and sold shares of the business. Berry Wealth Group LP raised its position in Globus Medical by 4.2% in the first quarter. Berry Wealth Group LP now owns 3,553 shares of the medical device company's stock worth $260,000 after purchasing an additional 144 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Globus Medical by 2.7% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,787 shares of the medical device company's stock worth $479,000 after purchasing an additional 150 shares in the last quarter. HB Wealth Management LLC raised its position in Globus Medical by 4.7% in the first quarter. HB Wealth Management LLC now owns 3,804 shares of the medical device company's stock worth $278,000 after purchasing an additional 170 shares in the last quarter. Whittier Trust Co. increased its holdings in shares of Globus Medical by 46.5% during the first quarter. Whittier Trust Co. now owns 580 shares of the medical device company's stock worth $42,000 after buying an additional 184 shares in the last quarter. Finally, Parallel Advisors LLC raised its stake in shares of Globus Medical by 62.1% in the first quarter. Parallel Advisors LLC now owns 504 shares of the medical device company's stock valued at $37,000 after acquiring an additional 193 shares during the last quarter. 95.16% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on GMED. Wells Fargo & Company cut their price objective on Globus Medical from $76.00 to $66.00 and set an "overweight" rating for the company in a research report on Friday, August 8th. Needham & Company LLC reiterated a "hold" rating on shares of Globus Medical in a research report on Monday, July 21st. Piper Sandler cut their target price on shares of Globus Medical from $100.00 to $80.00 and set an "overweight" rating on the stock in a research note on Friday, May 9th. Canaccord Genuity Group cut their target price on shares of Globus Medical from $97.00 to $90.00 and set a "buy" rating on the stock in a research note on Tuesday, July 22nd. Finally, Wall Street Zen raised shares of Globus Medical from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $87.64.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Globus Medical Company Profile

Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.